CPR‑PNH‑001
Paroxysmal Nocturnal Hemoglobinuria
ApprovedActive
Key Facts
Indication
Paroxysmal Nocturnal Hemoglobinuria
Phase
Approved
Status
Active
Company
About Chugai Pharmabody Research
CPR pioneers antibody and cyclic peptide drug discovery to address unmet medical needs worldwide.
View full company profileTherapeutic Areas
Other Paroxysmal Nocturnal Hemoglobinuria Drugs
| Drug | Company | Phase |
|---|---|---|
| Crovalimab | Chugai Pharmaceutical | Phase III / Marketed |